The Company holds an Virtual Investor Event in conjunction with the American College of Cardiology/World Heart Federation to discuss MK-0616 and Sotatercept on March 6 at 7 pm. Webcast Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRK:
- Merck says MK-0616 ‘significantly reduced’ LDL-C in Phase 2b study
- Merck: FDA approves IM route of administration for MMRV family of vaccines
- Merck initiated with a Buy at Jefferies
- Merck to hold a virtual investor event
- Piper Sandler pharmaceuticals analysts to hold analyst/industry conference call